Cyient is grappling with multiple challenges, including disappointing Q3 results, a downward revision in FY25 growth guidance, and the CEO's resignation, all of which have dampened investor sentiment.
Dr. Reddy's Laboratories shares in Friday's trade slipped by over 6 per cent in early trade to the day's low price of Rs 1,203.6 after the pharma major posted weak performance during the December ...
On July 11, It Begins. Superman - Only in Theaters 2025. Traveling over our heads at hypersonic speeds beyond Mach 7, lies the future of spy plane technology. It can be anywhere in the world in one ...